A detailed history of Red Tortoise LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Red Tortoise LLC holds 726 shares of NVO stock, worth $74,509. This represents 0.04% of its overall portfolio holdings.

Number of Shares
726
Previous 726 -0.0%
Holding current value
$74,509
Previous $103,000 16.5%
% of portfolio
0.04%
Previous 0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$102.11 - $135.92 $16,950 - $22,562
166 Added 29.64%
726 $93,000
Q3 2023

Nov 02, 2023

BUY
$90.94 - $199.54 $25,463 - $55,871
280 Added 100.0%
560 $50,000
Q2 2023

Jul 26, 2023

SELL
$155.98 - $172.65 $7,019 - $7,769
-45 Reduced 13.85%
280 $45,000
Q1 2023

May 16, 2023

SELL
$132.34 - $159.14 $21,439 - $25,780
-162 Reduced 33.26%
325 $51,000
Q4 2022

Feb 01, 2023

BUY
$102.55 - $135.33 $49,941 - $65,905
487 New
487 $65,000
Q3 2021

Nov 07, 2022

BUY
$84.42 - $106.62 $44,151 - $55,762
523 New
523 $52,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Red Tortoise LLC Portfolio

Follow Red Tortoise LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Tortoise LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Tortoise LLC with notifications on news.